Bio

Bio is the Cellular Frontier: mastering life's building blocks to cure disease and unlock human potential. Winklevoss Capital's bio investments back founders working at that level.

Colossal Biosciences is solving extinction. Luna Health is bringing automated insulin delivery to the majority of people living with diabetes who use insulin pens. Superpower Health is building a digital clinic to help people live longer, prevent disease, and feel their best. Klura Labs uses real antimicrobial science to pave the way for a safer planet, one product and surface at a time. Infinita is a biotech acceleration city network.

Health reaches into our consumer portfolio too, with companies like Kindbody, which offers fertility, gynecology, and wellness services in modern, tech-enabled clinics.

Bio is one of our Four Frontiers of Focus, alongside Crypto, Space, and Energy. Read the thinking behind them in Investing in builders on the frontier.